Switch to:
Array BioPharma, Inc. (NAS:ARRY)
EV/EBIT
0.00 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Array BioPharma, Inc.'s enterprise value is $457.23 Mil. Array BioPharma, Inc.'s operating income for the trailing twelve months (TTM) ended in Dec. 2013 was $-49.76 Mil. Therefore, Array BioPharma, Inc.'s EV/EBIT ratio for today is 0.00.

ARRY' s 10-Year EV/EBIT Range
Min: 6082.4   Max: 8002.5
Current: 0

6082.4
8002.5

During the past 13 years, the highest EV/EBIT Ratio of Array BioPharma, Inc. was 8002.50. The lowest was 6082.40. And the median was 6742.40.

ARRY's EV/EBITis ranked lower than
73% of the 478 Companies
in the Global Biotechnology industry.

( Industry Median: 20.00 vs. ARRY: 0.00 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Array BioPharma, Inc.'s enterprise value for the quarter that ended in Dec. 2013 was $606.85 Mil. Array BioPharma, Inc.'s Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was $-49.76 Mil. Array BioPharma, Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 was 0.00%.


Definition

Array BioPharma, Inc.'s EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=457.234/-49.756
=

Array BioPharma, Inc.'s current Enterprise Value is $457.23 Mil.
Array BioPharma, Inc.'s Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was -18.775 (Mar. 2013 ) + -3.665 (Jun. 2013 ) + -13.313 (Sep. 2013 ) + -14.003 (Dec. 2013 ) = $-49.76 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Array BioPharma, Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Dec. 2013 )=Operating Income (TTM)/Enterprise Value (Q: Dec. 2013 )
=-49.756/606.8527
= %

Array BioPharma, Inc.'s Enterprise Value for the quarter that ended in Dec. 2013 was $606.85 Mil.
Array BioPharma, Inc.'s Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was -18.775 (Mar. 2013 ) + -3.665 (Jun. 2013 ) + -13.313 (Sep. 2013 ) + -14.003 (Dec. 2013 ) = $-49.76 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Array BioPharma, Inc. Annual Data

Jun04Jun05Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13
ev2ebit 0.000.000.000.000.000.000.000.000.000.00

Array BioPharma, Inc. Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
ev2ebit 0.000.000.000.000.000.000.000.000.000.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide